Author Berg, Daniela

1 to 20 of 27 Items

2004 | Journal Article
Novel homozygous p.E64D mutation in DJ1 in early onset Parkinson disease (PARK7)
Hering, R.; Strauss, K. A.; Tao, X.; Bauer, A.; Woitalla, D.; Mietz, E. M. & Bauer, P. et al. (2004)
Human Mutation, 24(4) pp. 321-329. DOI: https://doi.org/10.1002/humu.20089
Details DOI PMID PMC WoS

2005 | Journal Article
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
Strauss, K. M.; Martins, L. M.; Plun-Favreau, H.; Marx, F. P.; Kautzmann, S.; Berg, D. & Gasser, T. et al. (2005)
Human Molecular Genetics, 14(15) pp. 2099-2111. DOI: https://doi.org/10.1093/hmg/ddi215
Details DOI PMID PMC WoS

2010 | Journal Article
Poor effect of guideline based treatment of restless legs syndrome in clinical practice
Godau, J.; Spinnler, N.; Wevers, A.-K.; Trenkwalder, C. & Berg, D. (2010)
Journal of Neurology Neurosurgery & Psychiatry, 81(12) pp. 1390-1395. DOI: https://doi.org/10.1136/jnnp.2010.211417
Details DOI PMID PMC WoS

2011 | Journal Article |
Parkinson's Disease and Dementia: A Longitudinal Study (DEMPARK)
Balzer-Geldsetzer, M.; da Costa, A. S. F. B.; Kronenbuerger, M.; Schulz, J. B.; Roeske, S.; Spottke, A. & Wuellner, U. et al. (2011)
Neuroepidemiology, 37(3-4) pp. 168-176. DOI: https://doi.org/10.1159/000331490
Details DOI PMID PMC WoS

2011 | Journal Article
AFQ056 Treatment of Levodopa-Induced Dyskinesias: Results of 2 Randomized Controlled Trials
Berg, D.; Godau, J.; Trenkwalder, C.; Eggert, K.; Csoti, I.; Storch, A. & Huber, H. et al. (2011)
Movement Disorders, 26(7) pp. 1243-1250. DOI: https://doi.org/10.1002/mds.23616
Details DOI PMID PMC WoS

2013 | Journal Article
Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany
Stiasny-Kolster, K.; Berg, D.; Hofmann, W. E.; Berkels, R.; Grieger, F.; Lauterbach, T. & Schollmayer, E. et al. (2013)
Sleep Medicine, 14(6) pp. 475-481. DOI: https://doi.org/10.1016/j.sleep.2013.02.013
Details DOI PMID PMC WoS

2015 | Journal Article
Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD
Lerche, S.; Liepelt-Scarfone, I.; Alves, G.; Barone, P.; Behnke, S.; Ben-Shlomo, Y. & Berendse, H. W. et al. (2015)
Neuroepidemiology, 45(4) pp. 282-297. DOI: https://doi.org/10.1159/000439221
Details DOI PMID PMC WoS

2016 | Journal Article |
Validation of conversion between mini-mental state examination and montreal cognitive assessment
Lawton, M.; Kasten, M.; May, M. T.; Mollenhauer, B.; Schaumburg, M.; Liepelt-Scarfone, I. & Maetzler, W. et al. (2016)
Movement Disorders, 31(4) pp. 593-596. DOI: https://doi.org/10.1002/mds.26498
Details DOI PMID PMC WoS

2016 | Journal Article |
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach (vol 123, pg 439, 2016)
Levin, J.; Maass, S.; Schuberth, M.; Respondek, G.; Paul, F.; Mansmann, U. & Oertel, W. H. et al. (2016)
Journal of Neural Transmission, 123(11) pp. 1357-1358. DOI: https://doi.org/10.1007/s00702-016-1602-x
Details DOI PMID PMC WoS

2016 | Journal Article | Letter Note |
Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies
Lerche, S.; Heinzel, S.; Alves, G. W.; Barone, P.; Behnke, S.; Ben-Shlomo, Y. & Berendse, H. W. et al. (2016)
Frontiers in Aging Neuroscience, 8 art. 121. DOI: https://doi.org/10.3389/fnagi.2016.00121
Details DOI PMID PMC WoS

2016 | Journal Article
A Placebo-Controlled Trial of AQW051 in Patients With Moderate to Severe Levodopa-Induced Dyskinesia
Trenkwalder, C.; Berg, D.; Rascol, O.; Eggert, K.; Ceballos-Baumann, A.; Corvol, J.-C. & Storch, A. et al. (2016)
Movement Disorders, 31(7) pp. 1049-1054. DOI: https://doi.org/10.1002/mds.26569
Details DOI PMID PMC WoS

2017 | Journal Article
Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease
Trezzi, J.-P.; Galozzi, S.; Jaeger, C.; Barkovits, K.; Brockmann, K.; Maetzler, W. & Berg, D. et al. (2017)
Movement Disorders, 32(10) pp. 1401-1408. DOI: https://doi.org/10.1002/mds.27132
Details DOI

2018 | Journal Article
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)
Stankevich, Y.; Lueken, U.; Balzer-Geldsetzer, M.; Dodel, R.; Gräber-Sultan, S.; Berg, D. & Liepelt-Scarfone, I. et al. (2018)
American Journal of Geriatric Psychiatry, 26(10) pp. 1079-1090. DOI: https://doi.org/10.1016/j.jagp.2018.06.012
Details DOI

2019 | Journal Article
Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
Levin, J.; Maaß, S.; Schuberth, M.; Giese, A.; Oertel, W. H; Poewe, W. & Trenkwalder, C. et al. (2019)
The Lancet Neurology, 18(8) pp. 724-735. DOI: https://doi.org/10.1016/S1474-4422(19)30141-3
Details DOI

2019 | Journal Article
Cognitive decline in Parkinson’s disease: the impact of the motor phenotype on cognition
Wojtala, J.; Heber, I. A.; Neuser, P.; Heller, J.; Kalbe, E.; Rehberg, S. P & Storch, A. et al. (2019)
Journal of Neurology, Neurosurgery & Psychiatry, 90(2) pp. 171-179. DOI: https://doi.org/10.1136/jnnp-2018-319008
Details DOI

2019 | Journal Article
A case of CLIPPERS syndrome responsive to tocilizumab
Rempe, T.; Becktepe, J. S.; Metz, I. ; Brück, W. ; Stürner, K. H.; Deuschl, G. & Berg, D. et al. (2019)
Neurology - Neuroimmunology Neuroinflammation, 6(3) pp. e545. DOI: https://doi.org/10.1212/NXI.0000000000000545
Details DOI

2019 | Journal Article |
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
Hopfner, F.; Müller, S. H.; Steppat, D.; Miller, J.; Schmidt, N.; Wandinger, K.-P. & Leypoldt, F. et al. (2019)
Translational Neurodegeneration, 8(1) art. 11. DOI: https://doi.org/10.1186/s40035-019-0153-0
Details DOI PMID PMC

2021 | Journal Article
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study
Lillig, R.; Ophey, A.; Schulz, J. B.; Reetz, K.; Wojtala, J.; Storch, A. & Liepelt-Scarfone, I. et al. (2021)
Parkinsonism & Related Disorders, 90 pp. 90-97. DOI: https://doi.org/10.1016/j.parkreldis.2021.07.034
Details DOI

Göttingen All

issue date

ASC DESC

10 20 50 100